Page 64 - 《南京医科大学学报（自然科学版）》2026年第3期

第46卷第3期
·372 · 南 京 医 科 大 学 学 报 2026年3月

的作用，帮助更多癌症患者实现生育愿望。 ［10］ CONFORTI A，CARBONE L，DI GIROLAMO R，et al.
利益冲突声明： Therapeutic management in women with a diminished
所有作者声明无利益冲突。 ovarian reserve：a systematic review and meta⁃analysis of
Conflict of Interests： randomized controlled trials［J］. Fertil Steril，2025，123
The authors declare that there is no conflict of interests. （3）：457-476
作者贡献声明： ［11］DEVILLERS M M，FRANÇOIS C M，CHESTER M，et al.
陶慧敏负责文献检索、资料整理以及初稿撰写；徐嗣亮 Androgen receptor signaling regulates follicular growth
负责论文审阅和指导；侯振提供监督指导。 and steroidogenesis in interaction with gonadotropins in
Author’s Contributions： the ovary during mini⁃puberty in mice［J］. Front Endocri⁃
TAO Huimin was responsible for literature search，data col⁃ nol（Lausanne），2023，14：1130681
lection，and drafting the initial manuscript；XU Siliang was re⁃ ［12］SIEGEL R L，MILLER K D，WAGLE N S，et al. Cancer
sponsible for review and supervision，and HOU Zhen provided statistics，2023［J］. CA A Cancer J Clin，2023，73（1）：
oversight guidance. 17-48
［13］SU H I，LACCHETTI C，LETOURNEAU J，et al. Fertility
［参考文献］
preservation in people with cancer ：ASCO guideline
［1］ YANG A M，CUI N，SUN Y F，et al. Letrozole for Female
update［J］. J Clin Oncol，2025，43（12）：1488-1515
Infertility［J］. Front Endocrinol（Lausanne），2021，12： ［14］OKTAY K，HOURVITZ A，SAHIN G，et al. Letrozole
676133
reduces estrogen and gonadotropin exposure in women
［2］ HONG Y H，PARK C，PAIK H，et al. Fertility preserva⁃ with breast cancer undergoing ovarian stimulation before
tion in young women with breast cancer：a review［J］. J
chemotherapy［J］. J Clin Endocrinol Metab，2006，91
Breast Cancer，2023，26（3）：221-242 （10）：3885-3890
［3］ KALTSAS A，EFTHIMIOU A，ROIDOS C，et al. Letrozole ［15］SACHDEV P A，AYAD N G，CONSTANTINOU C. Breast
at the crossroads of efficacy and fetal safety in ovulation cancer treatment and fertility preservation：a narrative
Induction：a narrative review［J］. Biomedicines，2025，13 review of impacts，strategies and ethical considerations［J］.
（9）：2051 Curr Oncol Rep，2024，26（12）：1575-1585
［4］ GENERALI D，BERARDI R，CARUSO M，et al. Corrigen⁃ ［16］ REDDY J，OKTAY K. Ovarian stimulation and fertility
dum：aromatase inhibitors：the journey from the state of preservation with the use of aromatase inhibitors in women
the art to clinical open questions［J］. Front Oncol，2024， with breast cancer［J］. Fertil Steril，2012，98（6）：1363-
14：1369562 1369
［5］ SCOTT L J，KEAM S J. Letrozole：in postmenopausal hor⁃ ［17］ OKTAY K，BUYUK E，LIBERTELLA N，et al. Fertility
mone ⁃ responsive early ⁃ stage breast cancer［J］. Drugs， preservation in breast cancer patients：a prospective
2006，66（3）：353-362 controlled comparison of ovarian stimulation with tamoxi⁃
［6］ ZHANG Y，ZHAO L，LIU Y，et al. Adverse event profiles fen and letrozole for embryo cryopreservation［J］. J Clin
of the third ⁃ generation aromatase inhibitors：analysis of Oncol，2005，23（19）：4347-4353
spontaneous reports submitted to FAERS［J］. Biomedi⁃ ［18］ SONIGO C，SERMONDADE N，CALVO J，et al. Impact
cines，2024，12（8）：1708 of letrozole supplementation during ovarian stimulation
［7］ GOSWAMI S K，DAS T，CHATTOPADHYAY R，et al. A for fertility preservation in breast cancer patients［J］. Eur
randomized single⁃blind controlled trial of letrozole as a J Obstet Gynecol Reprod Biol X，2019，4：100049
low ⁃ cost IVF protocol in women with poor ovarian re⁃ ［19］REVELLI A，PORCU E，LEVI SETTI P E，et al. Is letro⁃
sponse：a preliminary report［J］. Hum Reprod，2004，19 zole needed for controlled ovarian stimulation in patients
（9）：2031-2035 with estrogen receptor⁃positive breast cancer?［J］. Gyne⁃
［8］ YUSUF A N M，AMRI M F，UGUSMAN A，et al. Hyper⁃ col Endocrinol，2013，29（11）：993-996
androgenism and its possible effects on endometrial ［20］ MARKLUND A，ELORANTA S，WIKANDER I，et al.
receptivity：a review［J］. Int J Mol Sci，2023，24（15）：12026 Efficacy and safety of controlled ovarian stimulation using
［9］ WANG C，WEN Y X，MAI Q Y. Impact of metabolic GnRH antagonist protocols for emergency fertility preser⁃
disorders on endometrial receptivity in patients with vation in young women with breast cancer⁃a prospective
polycystic ovary syndrome［J］. Exp Ther Med，2022，23 nationwide Swedish multicenter study［J］. Hum Reprod，
（3）：221 2020，35（4）：929-938